These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 14767470

  • 1. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.
    Lee LF, Louie MC, Desai SJ, Yang J, Chen HW, Evans CP, Kung HJ.
    Oncogene; 2004 Mar 18; 23(12):2197-205. PubMed ID: 14767470
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
    Lee LF, Guan J, Qiu Y, Kung HJ.
    Mol Cell Biol; 2001 Dec 18; 21(24):8385-97. PubMed ID: 11713275
    [Abstract] [Full Text] [Related]

  • 3. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 4. Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells.
    Slack JK, Adams RB, Rovin JD, Bissonette EA, Stoker CE, Parsons JT.
    Oncogene; 2001 Mar 08; 20(10):1152-63. PubMed ID: 11313859
    [Abstract] [Full Text] [Related]

  • 5. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J, Zhu J, Goodman OB, Pestell RG, Schlegel PN, Nanus DM, Shen R.
    Oncogene; 2006 Mar 30; 25(14):2011-21. PubMed ID: 16434977
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.
    Araki S, Omori Y, Lyn D, Singh RK, Meinbach DM, Sandman Y, Lokeshwar VB, Lokeshwar BL.
    Cancer Res; 2007 Jul 15; 67(14):6854-62. PubMed ID: 17638896
    [Abstract] [Full Text] [Related]

  • 7. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer.
    Brunton VG, Ozanne BW, Paraskeva C, Frame MC.
    Oncogene; 1997 Jan 23; 14(3):283-93. PubMed ID: 9018114
    [Abstract] [Full Text] [Related]

  • 8. Angiogenesis is not mediated by prostate cancer neuropeptides.
    Busby JE, Shih SJ, Yang JC, Kung HJ, Evans CP.
    Angiogenesis; 2003 Jan 23; 6(4):289-93. PubMed ID: 15166497
    [Abstract] [Full Text] [Related]

  • 9. EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration.
    Rosenfeldt HM, Hobson JP, Maceyka M, Olivera A, Nava VE, Milstien S, Spiegel S.
    FASEB J; 2001 Dec 23; 15(14):2649-59. PubMed ID: 11726541
    [Abstract] [Full Text] [Related]

  • 10. Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells.
    Fu YM, Yu ZX, Li YQ, Ge X, Sanchez PJ, Fu X, Meadows GG.
    Nutr Cancer; 2003 Dec 23; 45(1):60-73. PubMed ID: 12791506
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.
    Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, Klocker H, Culig Z.
    Cancer Res; 1998 Oct 15; 58(20):4640-5. PubMed ID: 9788616
    [Abstract] [Full Text] [Related]

  • 12. Collagen IV regulates Caco-2 migration and ERK activation via alpha1beta1- and alpha2beta1-integrin-dependent Src kinase activation.
    Sanders MA, Basson MD.
    Am J Physiol Gastrointest Liver Physiol; 2004 Apr 15; 286(4):G547-57. PubMed ID: 14604860
    [Abstract] [Full Text] [Related]

  • 13. Transactivation of the epidermal growth factor receptor mediates muscarinic stimulation of focal adhesion kinase in intestinal epithelial cells.
    Calandrella SO, Barrett KE, Keely SJ.
    J Cell Physiol; 2005 Apr 15; 203(1):103-10. PubMed ID: 15389641
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II induces focal adhesion kinase/paxillin phosphorylation and cell migration in human umbilical vein endothelial cells.
    Montiel M, de la Blanca EP, Jiménez E.
    Biochem Biophys Res Commun; 2005 Feb 25; 327(4):971-8. PubMed ID: 15652490
    [Abstract] [Full Text] [Related]

  • 15. The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell line.
    Kampa M, Papakonstanti EA, Alexaki VI, Hatzoglou A, Stournaras C, Castanas E.
    Exp Cell Res; 2004 Apr 01; 294(2):434-45. PubMed ID: 15023532
    [Abstract] [Full Text] [Related]

  • 16. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor.
    Kraus S, Gioeli D, Vomastek T, Gordon V, Weber MJ.
    Cancer Res; 2006 Nov 15; 66(22):11047-54. PubMed ID: 17108144
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation.
    Seaton A, Scullin P, Maxwell PJ, Wilson C, Pettigrew J, Gallagher R, O'Sullivan JM, Johnston PG, Waugh DJ.
    Carcinogenesis; 2008 Jun 15; 29(6):1148-56. PubMed ID: 18487223
    [Abstract] [Full Text] [Related]

  • 18. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y, Wolff DW, Lin MF, Tu Y.
    Mol Pharmacol; 2007 Jul 15; 72(1):73-85. PubMed ID: 17430995
    [Abstract] [Full Text] [Related]

  • 19. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD, Lambert JR, Nordeen SK.
    Mol Cancer Res; 2010 Dec 15; 8(12):1643-55. PubMed ID: 21047772
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO, Chun JY, Nadiminty N, Lou W, Gao AC.
    Prostate; 2007 May 15; 67(7):764-73. PubMed ID: 17373716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.